EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY 4.0

Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review

Luis Bouz Mkabaah iD, Darragh T McGovern, Eoin P Kerin iD, Thomas O Butler, Vinitha Richard iD, Aoife J Lowery, Michael J Kerin iD

International Journal of Molecular Sciences · 17.08.2026 · 27 (16) · 7345

DOI: 10.3390/ijms27167345 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.08.2026. Verfasst von Luis Bouz Mkabaah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Lambe Institute for Translational Research, University of Galway, H91 YR71 Galway, Ireland. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, MicroRNAs, Biomarkers, Tumor. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Breast Cancer Research Institute, Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) have emerged as promising biomarkers for treatment response prediction in breast cancer. However, the role of circulating and tumour-derived miRNAs in predicting pathological complete response (pCR) following neoadjuvant therapy in HER2-positive (HER2+) breast cancer remains incompletely defined. To systematically evaluate the association between miRNA expression profiles and pCR in HER2+ breast cancer undergoing neoadjuvant systemic therapy, including chemotherapy with HER2-targeted agents. A systematic review of PUBMED, EMBASE, SCOPUS, and WEB OF SCIENCE databases was performed according to PRISMA guidelines. Studies evaluating circulating or tumour-derived miRNAs associated with pCR following neoadjuvant therapy in HER2+ breast cancer were included. Methodological quality was assessed using the QUIPS tool. Nine studies involving 937 HER2+ breast cancer patients were included. Overall, 39 unique miRNAs and four circulating miRNA signatures were associated with pCR outcomes. Seven studies evaluated circulating miRNAs, while two assessed tumour-derived miRNAs. The increased expression of six circulating miRNAs, four circulating signatures, and seventeen tumour-derived miRNAs was associated with pCR. Conversely, the increased expression of eleven circulating miRNAs and five tumour-derived miRNAs was associated with residual disease and non-pCR. MiR-210 was the only miRNA associated with response across more than one study, with an increased expression associated with residual disease in both circulating and tumour-derived analyses. Several circulating and tumour-derived miRNAs demonstrate potential as predictive biomarkers of pCR following HER2-targeted neoadjuvant therapy. However, substantial heterogeneity and limited validation currently restrict clinical implementation. Future prospective multicentre studies using standardised methodologies are required to clarify the role of miRNA profiling in personalised treatment strategies for HER2+ breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesMicroRNAsBiomarkers, TumorCirculating MicroRNAHumansFemalePathologic Complete ResponseNeoadjuvant TherapyGene Expression Regulation, NeoplasticGene Expression Profiling

Stichwörter der Autor:innen

HER2-positive breast cancerMicroRNAbiomarkersneoadjuvant therapypathological complete response

Substanzen

Erb-b2 Receptor Tyrosine KinasesMicroRNAsBiomarkers, TumorERBB2 protein, humanCirculating MicroRNA

Autor:innen und Institutionen

  • Department of Surgery, The Lambe Institute for Translational Research, University of Galway, H91 YR71 Galway, Ireland.

ORCID-Profile: Luis Bouz Mkabaah, Eoin P Kerin, Vinitha Richard, Michael J Kerin

Förderung

  • National Breast Cancer Research Institute, Ireland

Zitieren

APA

Bouz Mkabaah, L., McGovern, D. T., Kerin, E. P., Butler, T. O., Richard, V., Lowery, A. J., & Kerin, M. J. (2026). Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review. International Journal of Molecular Sciences, 27(16), 7345. https://doi.org/10.3390/ijms27167345

Vancouver

Bouz Mkabaah L, McGovern DT, Kerin EP, Butler TO, Richard V, Lowery AJ, et al. Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review. International Journal of Molecular Sciences. 2026;27(16):7345. doi:10.3390/ijms27167345

BibTeX
@article{BouzMkabaah2026,
  author = {Bouz Mkabaah, Luis and McGovern, Darragh T and Kerin, Eoin P and Butler, Thomas O and Richard, Vinitha and Lowery, Aoife J and Kerin, Michael J},
  title = {Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7345},
  doi = {10.3390/ijms27167345}
}
Kostenlos starten →